Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for primary choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients.
Company Details
- Employees
- 116
- Founded
- -
- Address
- 80 Guest St, Boston,massachusetts 02135,united States
- Phone
- 617-812-0078
- in****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aurabiosciences.com
- HQ
- Boston, Massachusetts
Aura Biosciences Questions
Aura Biosciences's helpline number is 617-812-0078
Aura Biosciences's website is aurabiosciences.com
Aura Biosciences's LinkedIn profile is https://www.linkedin.com/company/aurabiosciences
Aura Biosciences has
116 employees.
View email and phone details for 116
employees at Aura Biosciences.
Aura Biosciences's industry is
Biotechnology Research
Aura Biosciences's top competitors are
Eyepoint,
Verve Therapeutics,
Bridgebio,
Kura Oncology, Inc.,
Cullinan Therapeutics,
Mirum Pharmaceuticals, Inc.,
Scholar Rock,
Cellectar Biosciences, Inc.,
Syros Pharmaceuticals,
Alzheon, Inc..
Aura Biosciences's support email address is inquiries@aurabiosciences.com
Aura Biosciences's categories are Biotechnology Research
Aura Biosciences's founding year is 2009
